Human Tissue Microarray (CHO052-01A)
Liver and intrahepatic bile ducts tumor tissue microarray - 2 cores per case
- 25 Cholangiocarcinoma cases
- 1 Mucinous adenocarcinoma.
$200.00
Species | Human |
---|---|
Section Thickness | 5 µm |
Fixative | Formalin |
Total Cases | 26 |
Total Cores | 52 |
Core Diameter | 1.5 mm |
Storage | Short term RT |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
USBIOLAB
- A
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- B
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- C
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- D
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- E
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- F
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- LI
- G
- LI
- LI
- LI
- LI
-
No.
-
Map ID
-
Age
-
Sex
-
Organ
-
Pathology Diagnosis
-
Grade
-
TNM
-
Stage
-
Type
-
Block ID
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | Block ID |
---|---|---|---|---|---|---|---|---|---|---|
1
|
A1
|
70
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH03
|
2
|
A2
|
70
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH03
|
3
|
A3
|
35
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T4N1M0
|
III
|
Malignant Primary
|
CH07
|
4
|
A4
|
35
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T4N1M0
|
III
|
Malignant Primary
|
CH07
|
5
|
A5
|
72
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH10
|
6
|
A6
|
72
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH10
|
7
|
A7
|
57
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH103
|
8
|
A8
|
57
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH103
|
9
|
B1
|
56
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH111
|
10
|
B2
|
56
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH111
|
11
|
B3
|
47
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M1
|
IV
|
Malignant Primary
|
CH126
|
12
|
B4
|
47
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M1
|
IV
|
Malignant Primary
|
CH126
|
13
|
B5
|
57
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH150
|
14
|
B6
|
57
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH150
|
15
|
B7
|
49
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T4N1M0
|
III
|
Malignant Primary
|
CH155
|
16
|
B8
|
49
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T4N1M0
|
III
|
Malignant Primary
|
CH155
|
17
|
C1
|
71
|
M
|
Liver and intrahepatic bile ducts
|
Mucinous Adenocarcinoma
|
G2
|
T2N1M1
|
IV
|
Malignant Primary
|
CH160
|
18
|
C2
|
71
|
M
|
Liver and intrahepatic bile ducts
|
Mucinous Adenocarcinoma
|
G2
|
T2N1M1
|
IV
|
Malignant Primary
|
CH160
|
19
|
C3
|
43
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T4N1M0
|
III
|
Malignant Primary
|
CH169
|
20
|
C4
|
43
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T4N1M0
|
III
|
Malignant Primary
|
CH169
|
21
|
C5
|
69
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH22
|
22
|
C6
|
69
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CH22
|
23
|
C7
|
59
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T3N2M1
|
IV
|
Malignant Primary
|
CH315
|
24
|
C8
|
59
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T3N2M1
|
IV
|
Malignant Primary
|
CH315
|
25
|
D1
|
64
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH39
|
26
|
D2
|
64
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH39
|
27
|
D3
|
31
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
CH406
|
28
|
D4
|
31
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
CH406
|
29
|
D5
|
56
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH460
|
30
|
D6
|
56
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH460
|
31
|
D7
|
73
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH511
|
32
|
D8
|
73
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH511
|
33
|
E1
|
69
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
CH63
|
34
|
E2
|
69
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
CH63
|
35
|
E3
|
65
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N1M1
|
IV
|
Malignant Primary
|
CH69
|
36
|
E4
|
65
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N1M1
|
IV
|
Malignant Primary
|
CH69
|
37
|
E5
|
57
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH70
|
38
|
E6
|
57
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
CH70
|
39
|
E7
|
54
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T4N1M0
|
III
|
Malignant Primary
|
CH710
|
40
|
E8
|
54
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T4N1M0
|
III
|
Malignant Primary
|
CH710
|
41
|
F1
|
57
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T4N1M0
|
III
|
Malignant Primary
|
CH90
|
42
|
F2
|
57
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G3
|
T4N1M0
|
III
|
Malignant Primary
|
CH90
|
43
|
F3
|
34
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CHO1027
|
44
|
F4
|
34
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
CHO1027
|
45
|
F5
|
55
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N1M0
|
IV
|
Malignant Primary
|
3775-16
|
46
|
F6
|
55
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T3N1M0
|
IV
|
Malignant Primary
|
3775-16
|
47
|
F7
|
20
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2aN0M0
|
IIA
|
Malignant Primary
|
6816-16
|
48
|
F8
|
20
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2aN0M0
|
IIA
|
Malignant Primary
|
6816-16
|
49
|
G1
|
40
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2aN0M0
|
IIA
|
Malignant Primary
|
5244-16
|
50
|
G2
|
40
|
F
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2aN0M0
|
IIA
|
Malignant Primary
|
5244-16
|
51
|
G3
|
65
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M1
|
IV
|
Malignant Primary
|
IHC-04
|
52
|
G4
|
65
|
M
|
Liver and intrahepatic bile ducts
|
Cholangiocarcinoma
|
G2
|
T2N1M1
|
IV
|
Malignant Primary
|
IHC-04
|